Second, the CSF2 promoter contains the consensus STAT5-binding sequence where phosphorylated STAT5 is known to persistently transactivate CSF2 gene expression in autoimmune monocytes of type 1 diabetic patients 31. The gene discussed is STAT5A; the disease is type 1 diabetes mellitus.